"MCF-7 Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
	
	
		
			
			
				An estrogen responsive cell line derived from a patient with metastatic human breast ADENOCARCINOMA (at the Michigan Cancer Foundation.)
    
			
			
				
				
					
						| Descriptor ID | 
										
							D061986
						 | 			
					
					
						| MeSH Number(s) | 
						
							 A11.251.210.190.630 
						 | 
					
					
						| Concept/Terms | 
						
							MCF-7 Cells- MCF-7 Cells
 - Cell, MCF-7
 - Cells, MCF-7
 - MCF 7 Cells
 - MCF-7 Cell
 - MCF7 Cells
 - Cell, MCF7
 - Cells, MCF7
 - MCF7 Cell
 - Michigan Cancer Foundation 7 Cells
 
  
						 | 
					
					
				
			 
			
				Below are MeSH descriptors whose meaning is more general than "MCF-7 Cells".
				
			 
			
			
				Below are MeSH descriptors whose meaning is more specific than "MCF-7 Cells".
				
			 
		 
	 
 
                                        
                                            
	
	
		
			
			
					
				This graph shows the total number of publications written about "MCF-7 Cells" by people in this website by year, and whether "MCF-7 Cells" was a major or minor topic of these publications. 
				
					
                    To see the data from this visualization as text, 
click here. 
				 
                
		            | Year | Major Topic | Minor Topic | Total | 
|---|
| 2013 | 0 | 1 | 1 | 
| 2015 | 0 | 1 | 1 | 
| 2017 | 0 | 1 | 1 | 
                    To return to the timeline, 
click here.
                 
			 	
			
			
			
			
				Below are the most recent publications written about "MCF-7 Cells" by people in Profiles.
						
					
								- 
								
Evaluation and Adaptation of a Laboratory-Based cDNA Library Preparation Protocol for Retrospective Sequencing of Archived MicroRNAs from up to 35-Year-Old Clinical FFPE Specimens. Int J Mol Sci. 2017 Mar 14; 18(3).
															
								 
							
								- 
								
A novel IgM-H-ficolin complement pathway to attack allogenic cancer cells in vitro. Sci Rep. 2015 Jan 16; 5:7824.
															
								 
							
								- 
								
It's time for clinicians to reconsider their proscription against the use of soyfoods by breast cancer patients. Oncology (Williston Park). 2013 May; 27(5):430-7.